These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24250642)

  • 1. Suppressive effects of rosa damascena essential oil on naloxone- precipitated morphine withdrawal signs in male mice.
    Abbasi Maleki N; Abbasi Maleki S; Bekhradi R
    Iran J Pharm Res; 2013; 12(3):357-61. PubMed ID: 24250642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.
    Linseman MA
    Psychopharmacology (Berl); 1977 Oct; 54(2):159-64. PubMed ID: 412210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine.
    Ramabadran K
    Life Sci; 1983; 33 Suppl 1():385-8. PubMed ID: 6686634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen treatment suppresses withdrawal signs in morphine-dependent mice.
    Nicoara D; Zhang Y; Nelson JT; Brewer AL; Maharaj P; DeWald SN; Shirachi DY; Quock RM
    Brain Res; 2016 Oct; 1648(Pt A):434-437. PubMed ID: 27534375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats.
    Chen JC; Tao PL; Li JY; Wong CH; Huang EY
    Peptides; 2003 Mar; 24(3):477-81. PubMed ID: 12732348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
    Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome.
    Gibert-Rahola J; Maldonado R; Micó JA; Leonsegui I; Saavedra MC
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):927-33. PubMed ID: 3241876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.
    Taylor JR; Lewis VO; Elsworth JD; Pivirotto P; Roth RH; Redmond DE
    Psychopharmacology (Berl); 1991; 103(3):407-14. PubMed ID: 2057541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
    Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
    Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
    Pinelli A; Trivulzio S; Spezia R
    Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.
    Wen D; Zhao P; Hui R; Wang J; Shen Q; Gong M; Guo H; Cong B; Ma C
    Neuropharmacology; 2017 May; 118():199-208. PubMed ID: 28359771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.
    Shahidi S; Hasanein P
    Brain Res Bull; 2011 Aug; 86(1-2):118-22. PubMed ID: 21763761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats.
    Cappendijk SL; Duval SY; de Vries R; Dzoljic MR
    Neurosci Lett; 1995 Jan; 183(1-2):67-70. PubMed ID: 7538210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.